MedPath

A Comparative Study of Different Hypothermic Circulatory Arrest Strategies on Aortic Surgery.

Not Applicable
Conditions
Operation Time
ICU Stay
Neurological Disorder
Aneurysm
Re-Thoracotomy
Mechanical Ventilation Time
Morality
Hypothermic Circulatory Arrest Time
Aortic-cross Clamping Time
Cardiopulmonary Bypass Time
Interventions
Procedure: the temperature of hypothermic circulatory arrest
Registration Number
NCT03454633
Lead Sponsor
Xiaoping Fan. MD
Brief Summary

By comparing the clinical outcome of patients underwent different hypothermic circulatory arrest (mild hypothermic versus moderate hypothermic) during aortic arch surgery, this study aims to determine the optimal hypothermic circulatory arrest strategy for aortic surgery.

Detailed Description

Hypothermic circulatory arrest (HCA) is the cornerstone of aortic surgery. It provides a bloodless and still operative field. But the side effect of hypothermia also draws people's concern. With the development of surgical techniques and cardiopulmonary bypass (CPB) management, the temperature of HCA has been raised from deep hypothermia (14.1-20 degree) to moderate hypothermia (20.1-28 degree), and it has been a primary choice for many surgeons around the world. Some of surgeons still tried to push the limit and started using mild hypothermia (28.1-34 degree), and satisfactory outcome was obtained. However, the optimal temperature of HCA has not yet been determined.

In this randomized controlled study, 80 informed and consenting patients who are scheduled for total arch replacement with concomitant proximal aortic reconstruction will be randomized to mild (28.1-34 degree) or moderate (20.1-28 degree) hypothermia during circulatory arrest. Clinical outcomes of both groups will be analyzed to determine the optimal temperature for HCA.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria

1.Patients with confirmed diagnosis (i.e.aortic dissection, marfan syndrome, aortic arch aneurysm and so on), which require total aortic arch replacement.

Exclusion Criteria
  1. Preoperative heart attack or coma.
  2. Patients with surgical contraindication, including but not limited to severe cardiac,pulmonary,renal or hepatic insufficiency.
  3. Pre-existing heart condition or neurological disease.
  4. Variation of aortic arch or its branch vessels.
  5. Patient is currently on anticoagulation therapy or has other medical condition that compromises the coagulation.
  6. Patient with active infection.
  7. Allergy to anaesthetic or contrast agent.
  8. Pregnant or lactating female.
  9. Patient is already on other medical trial.
  10. Other medical, psychological or socioeconomics condition determined by investigator that is not eligible for the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mild hypothermiathe temperature of hypothermic circulatory arrestInitiation of circulatory arrest using the cardiopulmonary bypass at temperature 28.1 - 34 degrees Celsius
Moderate hypothermiathe temperature of hypothermic circulatory arrestInitiation of circulatory arrest using the cardiopulmonary bypass at temperature 20.1 - 28 degrees Celsius
Primary Outcome Measures
NameTimeMethod
Re-thoracotomyThrough the hospitalization, an average of 4 weeks.

Postoperative bleeding or other conditions require re-thoracotomy

Mortality3 months within surgery.

In-hospital Mortality or other related death

Neurological disorderThrough the hospitalization, an average of 4 weeks.

Any neurological event occur after surgery, including transient and permanent.

Secondary Outcome Measures
NameTimeMethod
Aorta-cross clamp timeDuring the operation

the time of aortic-cross clamp

Postoperative aneurysm1 year within the surgery

Aortic aneurysm develope after the surgery

Postoperative endoleak1 year within the surgery

Stent-graft endoleak occurs after the surgery.

Operation timeDuring the operation

the time of the entire surgery.

Time of mechanical ventilationThrough the use of ventilation, an average of 3 days.

the time of using respirator

Blood transfusionThrough the hospitalization, an average of 4 weeks.

the number of blood product during the hospitalization, including red blood cell, platelet, plasma and so on.

HCA timeDuring the operation

the time of hypothermic circulatory arrest

CPB timeDuring the operation

the time of cardiopulmonary bypass

Hospital stayThrough the hospitalization, an average of 4 weeks.

the time of hospitalization

ICU stayThrough the ICU stay, an average of 1 weeks.

the day of ICU treatment

DialysisThrough the hospitalization, an average of 4 weeks.

postoperative renal failure requiring dialysis

Trial Locations

Locations (1)

Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath